Sarepta Therapeutics (NASDAQ:SRPT) Upgraded to Hold at BidaskClub
Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by equities research analysts at BidaskClub from a "sell" rating to a "hold" rating in a research note issued on Thursday,…
Read More...
Read More...